Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,PPAR signaling pathway,0.003115430778973082,11.606197183098592,66.9838653433936,"['GK', 'ACSL1', 'PLTP']",0.38942884737163525,0,0,3
2,Antigen processing and presentation,0.0063902558658761365,8.782330345710628,44.37694810725147,"['HSPA5', 'HSPA1B', 'HSPA1A']",0.39939099161725855,0,0,3
3,Protein processing in endoplasmic reticulum,0.00998179981406097,4.124345390330045,19.000825652743377,"['XBP1', 'HSPH1', 'HSPA5', 'HSPA1B', 'HSPA1A']",0.4159083255858737,0,0,5
4,Complement and coagulation cascades,0.0205206148984084,10.048245614035087,39.05075108330785,"['F13A1', 'PLAT']",0.474096403239816,0,0,2
5,JAK-STAT signaling pathway,0.02783195868377284,4.893530675578897,17.526524255164855,"['PIM1', 'JAK3', 'PTPN2']",0.474096403239816,0,0,3
6,Longevity regulating pathway,0.03268312217256566,4.580147551978538,15.668210619379428,"['IGF1', 'HSPA1B', 'HSPA1A']",0.474096403239816,0,0,3
7,Regulation of actin cytoskeleton,0.034442848087718636,3.4591836734693877,11.65210075561702,"['CHRM3', 'LIMK2', 'PXN', 'IQGAP2']",0.474096403239816,0,0,4
8,Ferroptosis,0.035220694885573396,7.335470085470085,24.54537377132725,"['ACSL1', 'HMOX1']",0.474096403239816,0,0,2
9,Lipid and atherosclerosis,0.03633939733871368,3.3974937343358396,11.262191618641689,"['XBP1', 'HSPA5', 'HSPA1B', 'HSPA1A']",0.474096403239816,0,0,4
10,Measles,0.046606017774514785,3.946941925525757,12.101425022459988,"['JAK3', 'HSPA1B', 'HSPA1A']",0.474096403239816,0,0,3
11,Legionellosis,0.05561270320488186,5.602941176470588,16.1888223914156,"['HSPA1B', 'HSPA1A']",0.474096403239816,0,0,2
12,Transcriptional misregulation in cancer,0.056155351066657935,3.643965056159743,10.493283130114303,"['BCL6', 'PLAT', 'IGF1']",0.474096403239816,0,0,3
13,MicroRNAs in cancer,0.0595308701972919,3.552947313510694,10.023789111682582,"['DDIT4', 'PIM1', 'HMOX1']",0.474096403239816,0,0,3
14,Porphyrin and chlorophyll metabolism,0.06209064883532492,18.86849315068493,52.43855923106848,['HMOX1'],0.474096403239816,0,0,1
15,MAPK signaling pathway,0.06641911089555834,2.755918367346939,7.473417989029396,"['MAP3K8', 'IGF1', 'HSPA1B', 'HSPA1A']",0.474096403239816,0,0,4
16,Chemokine signaling pathway,0.0683775676095173,3.3439240091713067,8.970779940487557,"['CX3CR1', 'PXN', 'JAK3']",0.474096403239816,0,0,3
17,mTOR signaling pathway,0.0683775676095173,3.3439240091713067,8.970779940487557,"['SLC7A5', 'DDIT4', 'IGF1']",0.474096403239816,0,0,3
18,Fatty acid biosynthesis,0.07206265329245204,15.721461187214611,41.350891483681416,['ACSL1'],0.474096403239816,0,0,1
19,Primary immunodeficiency,0.07206265329245204,15.721461187214611,41.350891483681416,['JAK3'],0.474096403239816,0,0,1
20,beta-Alanine metabolism,0.09169392980517825,11.787671232876713,28.164272245960635,['DPYD'],0.5220535446409589,0,0,1
21,Pantothenate and CoA biosynthesis,0.09169392980517825,11.787671232876713,28.164272245960635,['DPYD'],0.5220535446409589,0,0,1
22,Neuroactive ligand-receptor interaction,0.09188142385680877,4.134057971014493,9.86905636731433,"['CHRM3', 'CYSLTR1']",0.5220535446409589,0,0,2
23,Signaling pathways regulating pluripotency of stem cells,0.09846238801564346,3.9606481481481484,9.181101838763475,"['IGF1', 'JAK3']",0.5351216739980623,0,0,2
24,Prostate cancer,0.10857399476078114,3.7260348583877994,8.27300223283161,"['PLAT', 'IGF1']",0.5471963317994782,0,0,2
25,Nicotinate and nicotinamide metabolism,0.11091538890926937,9.427397260273972,20.730729962378213,['NAMPT'],0.5471963317994782,0,0,1
26,Arachidonic acid metabolism,0.12973546972842312,7.853881278538813,16.03964990777995,['LTC4S'],0.5471963317994782,0,0,1
27,Ovarian steroidogenesis,0.12973546972842312,7.853881278538813,16.03964990777995,['IGF1'],0.5471963317994782,0,0,1
28,Toxoplasmosis,0.14404049469546565,3.110655737704918,6.027395703213642,"['HSPA1B', 'HSPA1A']",0.5471963317994782,0,0,2
29,Cholinergic synapse,0.14771258954012909,3.0600358422939067,5.8522783267826215,"['CHRM3', 'KCNQ5']",0.5471963317994782,0,0,2
30,Viral protein interaction with cytokine and cytokine receptor,0.14816244054674704,6.729941291585127,12.850459720701492,['CX3CR1'],0.5471963317994782,0,0,1
31,Neutrophil extracellular trap formation,0.15140405725219597,3.0110229276895946,5.684218537825703,"['FCGR3A', 'CASP4']",0.5471963317994782,0,0,2
32,Fluid shear stress and atherosclerosis,0.15511408834815196,2.9635416666666665,5.5228395918097055,"['HMOX1', 'PLAT']",0.5471963317994782,0,0,2
33,Arginine and proline metabolism,0.15723104758401962,6.280365296803653,11.618920198077799,['AZIN2'],0.5471963317994782,0,0,1
34,Fatty acid degradation,0.15723104758401962,6.280365296803653,11.618920198077799,['ACSL1'],0.5471963317994782,0,0,1
35,Estrogen signaling pathway,0.15884188796624163,2.9175213675213674,5.367789979517631,"['HSPA1B', 'HSPA1A']",0.5471963317994782,0,0,2
36,Fc gamma R-mediated phagocytosis,0.1625866755907069,2.872895622895623,5.21874139592475,"['FCGR3A', 'LIMK2']",0.5471963317994782,0,0,2
37,Taste transduction,0.1662044018821594,5.886986301369863,10.564414215063481,['CHRM3'],0.5471963317994782,0,0,1
38,HIF-1 signaling pathway,0.1663476848670414,2.8296019900497513,5.075386898034997,"['HMOX1', 'IGF1']",0.5471963317994782,0,0,2
39,PI3K-Akt signaling pathway,0.17792552130703373,2.130964893840656,3.678876985719712,"['DDIT4', 'IGF1', 'JAK3']",0.5563744556197667,0,0,3
40,Protein export,0.18386928981707948,5.231354642313547,8.85945683952591,['HSPA5'],0.5563744556197667,0,0,1
41,Drug metabolism,0.1925627670931271,4.9552992069214135,8.163028481167904,['DPYD'],0.5563744556197667,0,0,1
42,Calcium signaling pathway,0.20080704283652817,2.491228070175439,3.9994444936972173,"['CHRM3', 'CYSLTR1']",0.5563744556197667,0,0,2
43,FoxO signaling pathway,0.20080704283652817,2.491228070175439,3.9994444936972173,"['BCL6', 'IGF1']",0.5563744556197667,0,0,2
44,Aldosterone-regulated sodium reabsorption,0.20116487914966474,4.706849315068493,7.548046710598308,['IGF1'],0.5563744556197667,0,0,1
45,Pyrimidine metabolism,0.20116487914966474,4.706849315068493,7.548046710598308,['DPYD'],0.5563744556197667,0,0,1
46,Spliceosome,0.2085838071597542,2.4266381766381766,3.803547538418956,"['HSPA1B', 'HSPA1A']",0.5563744556197667,0,0,2
47,Pathways in cancer,0.21189618003630983,1.7411611219830399,2.701688048653082,"['PIM1', 'HMOX1', 'IGF1', 'JAK3']",0.5563744556197667,0,0,4
48,Cholesterol metabolism,0.21809878660294857,4.277708592777086,6.514125313169428,['PLTP'],0.5563744556197667,0,0,1
49,Mineral absorption,0.21809878660294857,4.277708592777086,6.514125313169428,['HMOX1'],0.5563744556197667,0,0,1
50,Systemic lupus erythematosus,0.22643244738996218,4.091125670041691,6.076584239834429,['FCGR3A'],0.5660811184749055,0,0,1
51,Glycerolipid metabolism,0.2346784739725353,3.9200913242009134,5.682324856315185,['GK'],0.5751923381679788,0,0,1
52,Staphylococcus aureus infection,0.24283777538534687,3.762739726027397,5.32563750559477,['FCGR3A'],0.5816695232433367,0,0,1
53,Focal adhesion,0.2518090319062618,2.1232833957553057,2.92818677143664,"['PXN', 'IGF1']",0.5816695232433367,0,0,2
54,NOD-like receptor signaling pathway,0.2518090319062618,2.1232833957553057,2.92818677143664,"['CASP4', 'NAMPT']",0.5816695232433367,0,0,2
55,Proteoglycans in cancer,0.27553691552155984,1.9874269005847953,2.5618601810478503,"['PXN', 'IGF1']",0.5816695232433367,0,0,2
56,VEGF signaling pathway,0.28236457502336665,3.1333333333333333,3.9622761678547875,['PXN'],0.5816695232433367,0,0,1
57,Hypertrophic cardiomyopathy,0.28236457502336665,3.1333333333333333,3.9622761678547875,['IGF1'],0.5816695232433367,0,0,1
58,Adipocytokine signaling pathway,0.29002210074844953,3.0318161732213875,3.752776448619314,['ACSL1'],0.5816695232433367,0,0,1
59,Melanoma,0.29002210074844953,3.0318161732213875,3.752776448619314,['IGF1'],0.5816695232433367,0,0,1
60,Peroxisome,0.29002210074844953,3.0318161732213875,3.752776448619314,['ACSL1'],0.5816695232433367,0,0,1
61,Prion disease,0.3049055277989867,1.5846250688488472,1.882143647303677,"['HSPA5', 'HSPA1B', 'HSPA1A']",0.5816695232433367,0,0,3
62,Thyroid hormone synthesis,0.3050961379683416,2.8472395184723953,3.38003873905766,['HSPA5'],0.5816695232433367,0,0,1
63,Central carbon metabolism in cancer,0.3050961379683416,2.8472395184723953,3.38003873905766,['SLC7A5'],0.5816695232433367,0,0,1
64,p53 signaling pathway,0.3050961379683416,2.8472395184723953,3.38003873905766,['IGF1'],0.5816695232433367,0,0,1
65,Dilated cardiomyopathy,0.3050961379683416,2.8472395184723953,3.38003873905766,['IGF1'],0.5816695232433367,0,0,1
66,Viral carcinogenesis,0.30712150827248175,1.830906148867314,2.1614063450713914,"['PXN', 'JAK3']",0.5816695232433367,0,0,2
67,Gastric acid secretion,0.3198543614876321,2.683757338551859,3.0591868299204488,['CHRM3'],0.5841376576977629,0,0,1
68,Pancreatic secretion,0.3198543614876321,2.683757338551859,3.0591868299204488,['CHRM3'],0.5841376576977629,0,0,1
69,Salivary secretion,0.3271170883107472,2.60882800608828,2.9152012118202313,['CHRM3'],0.5841376576977629,0,0,1
70,TGF-beta signaling pathway,0.3271170883107472,2.60882800608828,2.9152012118202313,['HAMP'],0.5841376576977629,0,0,1
71,Acute myeloid leukemia,0.3414137892110382,2.4708002883922133,2.6552704337269732,['PIM1'],0.5927322729358302,0,0,1
72,Long-term depression,0.3414137892110382,2.4708002883922133,2.6552704337269732,['IGF1'],0.5927322729358302,0,0,1
73,Inflammatory mediator regulation of TRP channels,0.3554107471792219,2.3465753424657536,2.4274878979358334,['IGF1'],0.6085800465397635,0,0,1
74,Human immunodeficiency virus 1 infection,0.3693875376752184,1.5809990662931839,1.5745311176173291,"['LIMK2', 'PXN']",0.6182258343069936,0,0,2
75,Insulin secretion,0.3758576940460905,2.1819050653074226,2.13509159504096,['CHRM3'],0.6182258343069936,0,0,1
76,Glioma,0.3825301079769892,2.13200498132005,2.0487457418845954,['IGF1'],0.6182258343069936,0,0,1
77,Leishmaniasis,0.389132143848779,2.0843226788432268,1.9672593877772249,['FCGR3A'],0.6182258343069936,0,0,1
78,Th1 and Th2 cell differentiation,0.39566453395647594,2.0387135199523527,1.8902718593901282,['JAK3'],0.6182258343069936,0,0,1
79,Cytokine-cytokine receptor interaction,0.39566453395647594,2.0387135199523527,1.8902718593901282,['CX3CR1'],0.6182258343069936,0,0,1
80,Non-small cell lung cancer,0.39566453395647594,2.0387135199523527,1.8902718593901282,['JAK3'],0.6182258343069936,0,0,1
81,Progesterone-mediated oocyte maturation,0.40212800303398444,1.9950451763334305,1.817455881904835,['IGF1'],0.6205679059166427,0,0,1
82,Breast cancer,0.4085232683402215,1.9531963470319635,1.7485138817713912,['IGF1'],0.6227488846649718,0,0,1
83,AGE-RAGE signaling pathway in diabetic complications,0.41485103986357913,1.913055633212189,1.6831747632321301,['PIM1'],0.6247756624451494,0,0,1
84,Natural killer cell mediated cytotoxicity,0.4211120202672337,1.8745205479452054,1.6211910915065244,['FCGR3A'],0.6266547920643359,0,0,1
85,TNF signaling pathway,0.43950113330634677,1.7676402171103645,1.4532035074529541,['MAP3K8'],0.6314671455550959,0,0,1
86,Bacterial invasion of epithelial cells,0.43950113330634677,1.7676402171103645,1.4532035074529541,['PXN'],0.6314671455550959,0,0,1
87,Toll-like receptor signaling pathway,0.43950113330634677,1.7676402171103645,1.4532035074529541,['MAP3K8'],0.6314671455550959,0,0,1
88,ErbB signaling pathway,0.4455018324613539,1.734652460679858,1.4025600448573232,['NRG1'],0.6328151029280594,0,0,1
89,Amyotrophic lateral sclerosis,0.45809289670109454,1.2129674599320057,0.946943420259976,"['XBP1', 'HSPA5', 'NRG1']",0.6361624410100822,0,0,3
90,T cell receptor signaling pathway,0.46312625705533983,1.6426339822158136,1.264426655057673,['MAP3K8'],0.6361624410100822,0,0,1
91,Th17 cell differentiation,0.46312625705533983,1.6426339822158136,1.264426655057673,['JAK3'],0.6361624410100822,0,0,1
92,Leukocyte transendothelial migration,0.468877353191056,1.6140765233821446,1.2225242394741607,['PXN'],0.6370616211835001,0,0,1
93,Oocyte meiosis,0.4912802093664896,1.5090587715422006,1.0725493711213414,['IGF1'],0.6603228620517333,0,0,1
94,Shigellosis,0.5035775040345911,1.1994301994301995,0.8228302844903919,"['CASP4', 'PXN']",0.6677212224369995,0,0,2
95,"Growth hormone synthesis, secretion and action",0.5074681290521196,1.438777660695469,0.9759536338355331,['IGF1'],0.6677212224369995,0,0,1
96,AMPK signaling pathway,0.5179766631601125,1.3954201594765896,0.9179423913703149,['IGF1'],0.6744487801563964,0,0,1
97,Hepatocellular carcinoma,0.5432900907440641,1.2975646879756468,0.7916596112255327,['HMOX1'],0.6874277957474713,0,0,1
98,Apelin signaling pathway,0.5530441769598792,1.2621251388374677,0.7475786739548447,['PLAT'],0.6874277957474713,0,0,1
99,Parkinson disease,0.5558312501157618,1.0852713178294573,0.6373695758908726,"['XBP1', 'HSPA5']",0.6874277957474713,0,0,2
100,Necroptosis,0.5625926973809564,1.2285508291276135,0.7066616544955143,['JAK3'],0.6874277957474713,0,0,1
101,Lysosome,0.5672912094945585,1.2124177192670342,0.6872983999975271,['SLC11A1'],0.6874277957474713,0,0,1
102,Endocytosis,0.5713614808199625,1.0538292529817954,0.5898632236011881,"['HSPA1B', 'HSPA1A']",0.6874277957474713,0,0,2
103,Pathways of neurodegeneration,0.5717966355059275,1.016696542893726,0.5683047811746589,"['CHRM3', 'XBP1', 'HSPA5']",0.6874277957474713,0,0,3
104,Osteoclast differentiation,0.5719399260618961,1.1966982788900598,0.6686208390136043,['FCGR3A'],0.6874277957474713,0,0,1
105,Chemical carcinogenesis,0.5900471684731907,1.1376545272302039,0.6001728298090344,['BCL6'],0.7024371053252271,0,0,1
106,Tight junction,0.6116217261688847,1.0714848055424342,0.5267861635092448,['YBX3'],0.721252035576515,0,0,1
107,Axon guidance,0.6240247005342453,1.0353120243531202,0.4882172535250553,['LIMK2'],0.722769050085585,0,0,1
108,Autophagy,0.6320754192447277,1.0125074449076832,0.46448430500416815,['DDIT4'],0.722769050085585,0,0,1
109,Yersinia infection,0.6360367640753147,1.0014729709824717,0.45316542993001807,['PXN'],0.722769050085585,0,0,1
110,Hepatitis B,0.6360367640753147,1.0014729709824717,0.45316542993001807,['JAK3'],0.722769050085585,0,0,1
111,Spinocerebellar ataxia,0.6438336527010736,0.9801009372746936,0.43155303589791166,['XBP1'],0.7250378971858937,0,0,1
112,Phagosome,0.6552210290172934,0.9496785015376014,0.4015075948468098,['FCGR3A'],0.7312734698853721,0,0,1
113,Rap1 signaling pathway,0.6769290226704445,0.8940990516332982,0.3488674830009533,['IGF1'],0.7414365312655987,0,0,1
114,Tuberculosis,0.6804135223690129,0.8854533594259621,0.3409478400002151,['FCGR3A'],0.7414365312655987,0,0,1
115,Alzheimer disease,0.6864586824988631,0.8463977676306443,0.31842266200823394,"['CHRM3', 'XBP1']",0.7414365312655987,0,0,2
116,Ras signaling pathway,0.6906460943046763,0.8604769152714358,0.31848638539630125,['IGF1'],0.7414365312655987,0,0,1
117,Non-alcoholic fatty liver disease,0.6939845932646004,0.8524569561392484,0.31140723047106555,['XBP1'],0.7414365312655987,0,0,1
118,Epstein-Barr virus infection,0.7101512914870358,0.8144676760394136,0.2787737523330085,['JAK3'],0.7522789104735549,0,0,1
119,Pathogenic Escherichia coli infection,0.7194437703222004,0.7932326425477111,0.26119319087516385,['CASP4'],0.7557182461367652,0,0,1
120,Human cytomegalovirus infection,0.7284422307568862,0.7730593607305936,0.24494150477828186,['PXN'],0.7587939903717565,0,0,1
121,Human T-cell leukemia virus 1 infection,0.7510696191534101,0.7238869863013698,0.20721766606101502,['JAK3'],0.7758983668940186,0,0,1
122,Human papillomavirus infection,0.7718349481206255,0.6804995970991137,0.17623888164855833,['PXN'],0.7908144960252309,0,0,1
123,Thermogenesis,0.7815671091069619,0.6606653620352251,0.16282379332397562,['ACSL1'],0.7942755173851239,0,0,1
124,Coronavirus disease,0.795402423048582,0.6329517733158191,0.1448871547974747,['F13A1'],0.8018169587183286,0,0,1
125,Salmonella infection,0.8373549428398241,0.551636453121155,0.09791946034018803,['CASP4'],0.8373549428398241,0,0,1
